American College of Cardiology6d
Discontinuing Drug Treatment in HFrEF, Race and Sacubitril/Valsartan Use in HF, Systolic BP Polygenic Risk Score Treatment Responses
In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heart ...
American College of Cardiology3d
CMS Releases 2025 Medicare Physician Fee Schedule and Hospital OPPS Final Rules
The Centers for Medicare and Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (PFS) final rule and the 2025 Hospital Outpatient Prospective Payment System (OPPS) and ...
American College of Cardiology5d
Participation in ACC Quality Improvement Campaign Associated With Reduced Risk of Post PCI Bleeding
Participation in ACC’s Reduce the Risk: PCI Bleed Campaign was associated with a significant reduction of bleeding events following PCI, according to a study published in Circulation: Cardiovascular ...
American College of Cardiology5d
Impact of Catheter Ablation of Electrical Storm on Survival
Benali K, Ninni S, Guenancia C, et al. After propensity score matching, patients who underwent catheter ablation (n = 288) and those treated with medical therapy alone (n = 288) did not present any ...
American College of Cardiology6d
TARGET-IV NA: BP-SES vs. DES in Patients With Chronic or Acute Coronary Syndromes Undergoing PCI
A biodegradable polymer sirolimus-eluting stent (BP-SES) was noninferior to currently-used second-generation drug-eluting stents (DES) in terms of target lesion failure (TLF) at one year in patients ...
American College of Cardiology4d
Predictors of Sudden Cardiac Events in Patients With Fontan Circulation
Wolfe NK, Schiff MD, Christopher AB, et al., on behalf of FORCE Investigators. The study made use of the FORCE (Fontan Outcomes Registry Using CMR Examinations) registry, which collects clinical and ...
American College of Cardiology6d
FLASH: AI-Based Quantitative Angiography Shows Promise For Assisting PCI
Results from the FLASH trial demonstrate the noninferiority of artificial intelligence-based fully automated quantitative coronary angiography (AI-QCA)-assisted PCI compared with optical coherence ...
American College of Cardiology4d
ACC Practice Made Perfect: Blueprint for Success: Crafting Your Service Line Strategic Plan
Welcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode two of four, Dr. Tom Draper talks with Mr. Adam DeJong and Dr. Malissa Wood about efforts required in the ...
American College of Cardiology6d
FAVOR III Europe: QFR-Guided Strategy vs. FFR-Guided Strategy in Patients With Intermediate Coronary Stenosis
A quantitative flow ratio (QFR)-guided strategy did not provide the same prognostic benefits as a fractional flow reserve (FFR)-guided strategy for patients with intermediate coronary stenosis, based ...
American College of Cardiology5d
Clinical Practice Algorithm For the Follow-Up of Unrepaired and Repaired Tetralogy of Fallot
Tetralogy of Fallot is the most common cyanotic congenital heart disease and requires surgical repair. Strategy and timing/type of intervention is variable and depends on clinical symptomatology and ...
American College of Cardiology6d
Functional Diagnostic Accuracy of Quantitative Flow Ratio in Online Assessment of Coronary Stenosis III Europe - FAVOR III Europe
The FAVOR III Europe trial showed that in patients with chronic or acute coronary syndrome, noninvasive functional testing of intermediate stenoses with quantitative flow ratio (QFR) resulted in more ...
American College of Cardiology6d
ACURATE neo2 vs. Approved TAVR Devices in All-Risk Patients With Severe AS - ACURATE IDE
The ACURATE IDE trial failed to demonstrate that the Acurate neo2 valve was noninferior to a commercially available valve. Patients with severe aortic stenosis were randomized to the Acurate neo2 self ...